Understanding COVID-19

Hank Green discusses the rapid changes in science news with Dr. Howard Bochner and Alexis Dahl. They explore how JAMA adapted to the pandemic, focusing on COVID-19 content and new communication methods. The conversation delves into mRNA vaccine development, unexpected COVID-19 findings, and treatments. Vaccine hesitancy and public trust are addressed, emphasizing the need for education. The discussion concludes with future challenges and the importance of leadership in pandemic preparedness.

What has been the impact of the pandemic on the number of submissions to JAMA?

How has the publication strategy of JAMA changed during the pandemic?

What are the advantages of mRNA vaccines compared to traditional vaccines?

What are some of the major changes in the types of articles published in JAMA since the pandemic began?

What role do asymptomatic and presymptomatic spread play in the pandemic according to the discussion?

How do corticosteroids affect patients with COVID-19 according to the conversation?

What is the significance of the term 'long haulers' in the context of COVID-19?

How can public trust in vaccines be improved according to the discussion?

What are the expected outcomes of the vaccination process as discussed?

What challenges do healthcare workers face during the pandemic as discussed in the interview?